Invivyd, Inc. (IVVD) Financial Ratios
6 years of historical data (2020–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
0.55
↓-60% vs avg
5yr avg: 1.37
30Y Low0.5·High2.4
ROE
↑
-34.0%
↓+57% vs avg
5yr avg: -78.4%
30Y Low-139%·High-34%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
IVVD Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Invivyd, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Market Cap | $102M | $425M | $53M | $432M | $162M | $804M | — |
| Enterprise Value | $-121993330 | $201M | $-15513247 | $233M | $74M | $262M | — |
| P/E Ratio → | -2.57 | — | — | — | — | — | — |
| P/S Ratio | 1.91 | 7.96 | 2.07 | — | — | — | — |
| P/B Ratio | 0.55 | 1.76 | 0.78 | 2.43 | 0.46 | 1.44 | — |
| P/FCF | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
IVVD EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 3.77 | -0.61 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — |
IVVD Profitability
Margins and return-on-capital ratios measuring operating efficiency
Invivyd, Inc. earns an operating margin of -104.0%. Operating margins have expanded from -696.8% to -104.0% over the past 3 years, signaling improving operational efficiency. A negative ROE of -34.0% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 93.0% | 93.0% | 93.6% | — | — | — | — |
| Operating Margin | -104.0% | -104.0% | -696.8% | — | — | — | — |
| Net Profit Margin | -98.2% | -98.2% | -669.4% | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| ROE | -34.0% | -34.0% | -138.7% | -74.5% | -52.8% | -92.0% | — |
| ROA | -25.8% | -25.8% | -94.7% | -64.9% | -48.1% | -61.5% | -95.4% |
| ROIC | -494.9% | -494.9% | — | -129.4% | -131.3% | — | — |
| ROCE | -35.8% | -35.8% | -143.6% | -79.2% | -54.1% | -68.5% | -107.4% |
IVVD Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $227M exceeds total debt of $2M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.93 | -1.01 | -1.12 | -0.25 | -0.97 | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | -5.25 | — | — |
Net cash position: cash ($227M) exceeds total debt ($2M)
IVVD Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Invivyd, Inc.'s current ratio of 7.24x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 6.50x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 4.47x to 7.24x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.24 | 7.24 | 1.62 | 4.47 | 15.06 | 9.94 | 8.98 |
| Quick Ratio | 6.50 | 6.50 | 1.62 | 4.47 | 15.06 | 9.94 | 8.98 |
| Cash Ratio | 6.64 | 6.64 | 1.12 | 3.99 | 14.86 | 9.53 | 8.80 |
| Asset Turnover | — | 0.19 | 0.20 | — | — | — | — |
| Inventory Turnover | 0.15 | 0.15 | — | — | — | — | — |
| Days Sales Outstanding | — | 95.09 | 160.60 | — | — | — | — |
IVVD Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Invivyd, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $172M | $119M | $110M | $108M | $111M | $111M |
Peer Comparison
Compare IVVD with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 IVVDYou | $102M | -2.6 | — | — | 93.0% | -104.0% | -34.0% | -494.9% | — |
 REGN | $64B | 14.8 | 15.3 | 15.6 | 85.4% | 24.9% | 14.9% | 8.9% | 0.7 |
 VRTX | $113B | 29.0 | 22.5 | 35.4 | 85.0% | 39.4% | 22.5% | 23.0% | 0.8 |
 MNKD | $1B | 183.0 | 29.9 | 82.6 | 82.5% | 11.1% | — | 21.6% | 9.3 |
 ADMA | $2B | 13.7 | 9.5 | 68.4 | 57.4% | 37.5% | 35.6% | 36.0% | 0.4 |
 SABS | $178M | -4.2 | — | — | — | — | 15.0% | -43.5% | — |
 ABBV | $403B | 96.1 | 16.5 | 22.6 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 |
 LLY | $1.1T | 49.4 | 35.4 | 119.3 | 83.8% | 45.6% | 101.2% | 41.8% | 1.4 |
 ALNY | $38B | 121.4 | 67.0 | 81.1 | 81.8% | 13.5% | 73.3% | 33.4% | 2.3 |
 RCKT | $300M | -1.4 | — | — | — | — | -60.3% | -62.4% | — |
 IMVT | $7B | -12.1 | — | — | — | — | -64.8% | — | — |
| Healthcare Median | — | 22.9 | 14.4 | 18.9 | 63.9% | -4.3% | -32.6% | -11.4% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 6 years · Updated daily
What if you invested $1,000 in IVVD 10 years ago?
Total return calculator · dividends reinvested
Calculate ReturnsHow much would $100/month in IVVD be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs IVVD Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationIVVD vs REGN — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Regeneron Pharmaceuticals, Inc..
Compare NowIVVD — Frequently Asked Questions
Quick answers to the most common questions about buying IVVD stock.
What is Invivyd, Inc.'s P/E ratio?
Invivyd, Inc.'s current P/E ratio is -2.6x. This places it at the 50th percentile of its historical range.
What is Invivyd, Inc.'s ROE?
Invivyd, Inc.'s return on equity (ROE) is -34.0%. The historical average is -78.4%.
Is IVVD stock overvalued?
Based on historical data, Invivyd, Inc. is trading at a P/E of -2.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Invivyd, Inc.'s profit margins?
Invivyd, Inc. has 93.0% gross margin and -104.0% operating margin.